OrthoPediatrics (KIDS) Earnings Analysis

OrthoPediatrics (KIDS) has no confirmed upcoming earnings date. Last quarter (2026-04-30) it missed with EPS -0.42 USD vs -0.38 USD est (-10.5%). It has beaten estimates in 3/4 recent quarters (75%). Trailing P/E -11.46.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does KIDS next report earnings?

No confirmed upcoming earnings date is currently scheduled for KIDS. This page updates as the calendar is published.

KIDS earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-30-0.42 USD-0.38 USD-10.5%Miss
2026-02-26-0.26 USD-0.37 USD+29.7%Beat
2025-03-04-0.29 USD-0.33 USD+12.1%Beat
2024-08-05-0.23 USD-0.31 USD+25.8%Beat

Beat rate: 3/4 (75%) over reported quarters with consensus data.

KIDS valuation and analyst view

Trailing P/E-11.46
Trailing EPS-1.67515 USD
Price / book1.35
Dividend yield0.00%
Market cap0.49B
Analyst consensusBuy (12 buy / 1 hold / 0 sell)
Avg price target21 USD

Related research pages

Frequently asked questions

When is OrthoPediatrics (KIDS)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for KIDS. This page updates as the calendar is published.

Did KIDS beat earnings last quarter?

In its 2026-04-30 report, KIDS posted EPS of -0.42 USD versus a -0.38 USD estimate — a miss of 10.5%.

What is KIDS's earnings track record?

Over the last 4 reported quarters with consensus data, KIDS beat estimates 3 times (75%).

What is KIDS's current P/E ratio and EPS?

KIDS trades at a trailing P/E of -11.46 on trailing EPS of -1.6751491605149322 USD.

What do analysts rate KIDS?

Analyst consensus is "Buy" across 13 ratings (0 strong buy, 12 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 21 USD.